Penumbra (PEN) Income from Continuing Operations (2014 - 2026)

Penumbra's (PEN) quarterly Income from Continuing Operations came in at 32588000.0 in Q1 2026, down 16.92% year-on-year from 39223000.0 in Q1 2025, and down 31.17% on a QoQ basis from 47343000.0 in Q4 2025.

Penumbra (PEN) Income from Continuing Operations (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Income from Continuing Operations data on file, last reported at 32588000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 16.92% year-over-year to 32588000.0 in Q1 2026; TTM through Mar 2026 was 171092000.0, a 305.59% increase from a year earlier, with the FY2025 full-year figure at 177687000.0, up 1168.11% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 32588000.0, down from 47343000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for PEN reached as high as 54218000.0 in Q4 2023 and fell as low as 60200000.0 in Q2 2024.
  • Historically, Income from Continuing Operations has averaged 18423823.53 across 5 years, with a median of 18936000.0 in 2023.
  • Across the five-year window, Income from Continuing Operations jumped 10737.97% in 2023 and slumped 417.91% in 2024, its largest moves.
  • Year by year, Income from Continuing Operations stood at 3877000.0 in 2022, then surged by 1298.45% to 54218000.0 in 2023, then plunged by 37.88% to 33682000.0 in 2024, then soared by 40.56% to 47343000.0 in 2025, then slumped by 31.17% to 32588000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 32588000.0 in Q1 2026, 47343000.0 in Q4 2025, and 45851000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Penumbra 12.48 Bn 11.87 Bn 253.41 Mn 32.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 32.59 Mn
Dec 31, 2025 47.34 Mn
Sep 30, 2025 45.85 Mn
Jun 30, 2025 45.31 Mn
Mar 31, 2025 39.22 Mn
Dec 31, 2024 33.68 Mn
Sep 30, 2024 29.48 Mn
Jun 30, 2024 -60.20 Mn
Mar 31, 2024 11.00 Mn
Dec 31, 2023 54.22 Mn
Sep 30, 2023 9.21 Mn
Jun 30, 2023 18.94 Mn
Mar 31, 2023 8.56 Mn
Dec 31, 2022 3.88 Mn
Sep 30, 2022 -2.27 Mn
Jun 30, 2022 -3.69 Mn
Mar 31, 2022 79,000.00
Dec 31, 2021 -24.63 Mn
Sep 30, 2021 8.03 Mn
Jun 30, 2021 8.30 Mn